Is the Repeatable Battery for the Assessment of Neuropsychological Status Factor Structure Appropriate for Inpatient Psychiatry? An Exploratory and Higher-Order Analysis

King, Loren C.; Bailie, Jason M.; Kinney, Dominique I.; Nitch, Stephen R.

doi:10.1093/arclin/acs062

Cited by 14 publications

(9 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), a brief neurocognitive battery, was used in our research (King et al, 2012;Moore et al, 2013), which contained 12 subtests and 5 alternate forms: immediate memory (vocabulary learning, story rehearsal), visuospatial skills (graphics depiction, line orientation), language (picture naming, semantic fluency), attention (digit span and digit symbol), and delayed memory (vocabulary recall, word recognition, story recall, and figure recall).…”

Section: Methodsmentioning

confidence: 99%

Metabolic Syndrome and Its Factors Affect Cognitive Function in Chronic Schizophrenia Complicated by Metabolic Syndrome

Zhan

Rao

et al. 2014

Journal of Nervous &Amp; Mental Disease

View full text Add to dashboard Cite

The aim of this study was to investigate the characteristics of cognitive function damage in chronic schizophrenia patients with metabolic syndrome (MS); 388 patients were divided into two groups: MS group (180 people with schizophrenia and MS) and non-MS group (208 people with schizophrenia but without MS). The Positive and Negative Syndrome Scale (PANSS) and the Treatment Emergent Symptom Scale (TESS) were used to evaluate clinical symptoms and drug adverse reaction. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was used to assess cognitive function. There was no significant change in PANSS (p = 0.53) and TESS score (p = 0.26) between the MS group and the non-MS group. However, RBANS total scale score as well as attention, immediate memory, and delayed memory scores in the MS group were significantly lower than those in the non-MS group (p < 0.05). There was no significant change in visuospatial skill (p = 0.07) and language scores (p = 0.08) between the two groups. Besides, course of disease, triglyceride, antipsychotic drug type, systolic pressure, negative symptom factor, and education level showed a notable significance for cognitive function damage in turn. MS might aggravate injury of cognitive function in chronic schizophrenia, especially in immediate memory, delayed memory, and attention.

show abstract

Section: Methodsmentioning

confidence: 99%

Metabolic Syndrome and Its Factors Affect Cognitive Function in Chronic Schizophrenia Complicated by Metabolic Syndrome

Zhan

Rao

et al. 2014

Journal of Nervous &Amp; Mental Disease

View full text Add to dashboard Cite

show abstract

“…Reaction time and accuracy data can be obtained from all tasks allowing for the quantification of change within and across various populations (the accumulation of evidence for the validity of our interpretation of the DalCAB in stroke and Parkinson's disease populations is ongoing). As a follow-up to research that has examined the reliability of DalCAB test scores and the validity of score interpretation (Butler et al, 2010), the current study sought to examine the factor structure of the DalCAB in a healthy young adult sample using exploratory factor analysis (EFA), a data reduction method used to identify possible underlying relationships among variables, including neuropsychological test batteries (e.g., King, Bailie, Kinney, & Nitch, 2012;Pineda & Merchan, 2003). Preliminary evidence for the validation of the interpretation of the DalCAB could be obtained if the variables derived from different DalCAB tasks presumed to measure the same component of attention (i.e., vigilance/alerting, orienting or executive control) cluster together and are associated with the same latent factor.…”

mentioning

confidence: 99%

Measuring the components of attention using the Dalhousie Computerized Attention Battery (DalCAB).

Jones¹,

Butler²,

Kintzel³

et al. 2015

Psychological Assessment

View full text Add to dashboard Cite

Using experimentally validated tests to measure the vigilance/alerting, orienting and executive control attention networks, we have developed a novel, theoretically driven battery for measuring attentional abilities, called the Dalhousie Computerized Attention Battery (DalCAB). The current study sought to examine the factor structure of the DalCAB as preliminary evidence for its validation as an assessment tool for the above-named attention networks. One hundred young, healthy adult participants (18 to 31 years) completed the DalCAB (simple reaction time, choice reaction time, dual task, go/no-go, visual search, vertical flanker, and item memory tasks). Exploratory factor analysis of task performance with promax rotation highlighted a 9-factor model, accounting for 54.66% of the shared variance. Factors 1, 2, and 5 are associated with measures reflecting the vigilance/alerting network (response speed, maintenance/preparation and consistency, respectively), Factor 3 is associated with the orienting network (searching measures). Factors 4, 6, 7, and 8 are associated with different aspects of the executive control network including: inhibition, working memory, filtering, and switching. The final factor is associated with vigilance/alerting (fatigue) and executive control (proactive interference). Our model provides preliminary evidence for the validation of our interpretation of the DalCAB as a measure of vigilance/alerting, orienting, and executive control attentional abilities, and contributes to the previously reported evidence for the validation of these tasks for measuring different aspects of attention. We also demonstrate the importance of each of the specific measures derived from the DalCAB tasks, and our results provide further behavioral evidence of the existence of multiple attention-related networks.

show abstract

“…Once scored, the RBANS produces 6 standardized index scores, including immediate and delayed memory, visuospatial/constructional, attention, language, and a total score. The RBANS is commonly used as a screening tool in briefer assessments and demonstrates good sensitivity to cognitive deficits commonly associated with schizophrenia spectrum disorders (Bailie et al, 2012; King et al, 2012; Toofanian Ross et al, 2015).…”

Section: Methodsmentioning

confidence: 99%

“…Thus, brief cognitive screeners are commonly used to assess for cognitive factors that may influence competency restoration (Kirkish & Sreenivasan, 1999). As one example, the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS; Randolph, 1998) is a brief screener that measures multiple cognitive domains and has demonstrated a sensitivity to severe cognitive deficits commonly found among individuals with schizophrenia spectrum disorders (Bailie et al, 2012; Dickerson et al, 2004; Gogos et al, 2010; Gold et al, 1999; Hobart et al, 1999; Iverson et al, 2009; King et al, 2012; Toofanian Ross et al, 2015; Wilk et al, 2002, 2004). Specifically, the RBANS Total Scale Index was determined to be the most appropriate RBANS index for assessing individuals with a schizophrenia spectrum diagnosis within a forensic inpatient setting (King et al, 2012) and has further been shown to predict LOS for individuals deemed IST (Toofanian Ross et al, 2015).…”

mentioning

confidence: 99%

The Clinical Utility of the NAB Judgment Subtest Among Individuals Diagnosed With Schizophrenia Spectrum Disorder Within a Forensic Inpatient Setting

et al. 2021

View full text Add to dashboard Cite

Executive functioning (EF) has been identified as a significant predictor in determining competence to stand trial. Individuals deemed incompetent to stand trial are provided a limited time frame before conservatorship is considered, thus, treatment providers practicing within inpatient facilities have a responsibility to efficiently identify factors that may lead to prolonged hospitalizations, in order to avoid delays in a defendant’s legal proceedings. Although previous studies have demonstrated the utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Total Index Score in predicting length of stay (LOS), the Neuropsychological Assessment Battery (NAB) Judgment subtest provides a measure of executive function, which is a domain not captured by the RBANS. The current study examined the relationship between both the RBANS and NAB Judgment performance as predictors of LOS among 63 individuals diagnosed with schizophrenia spectrum disorders undergoing competency restoration treatment. Additionally, sensitivity analyses were used to determine cutoff scores for individuals requiring additional competency services. Results indicated that the NAB Judgment subtest was more predictive of LOS than the RBANS Total Index Score. Additionally, a raw score of ≤9 on NAB Judgment was indicative of increased LOS. These results highlight the utility of the NAB Judgment subtest within a forensic inpatient setting.

show abstract

Is the Repeatable Battery for the Assessment of Neuropsychological Status Factor Structure Appropriate for Inpatient Psychiatry? An Exploratory and Higher-Order Analysis

Cited by 14 publications

References 28 publications

Metabolic Syndrome and Its Factors Affect Cognitive Function in Chronic Schizophrenia Complicated by Metabolic Syndrome

Metabolic Syndrome and Its Factors Affect Cognitive Function in Chronic Schizophrenia Complicated by Metabolic Syndrome

Measuring the components of attention using the Dalhousie Computerized Attention Battery (DalCAB).

The Clinical Utility of the NAB Judgment Subtest Among Individuals Diagnosed With Schizophrenia Spectrum Disorder Within a Forensic Inpatient Setting

Contact Info

Product

Resources

About